Scarica l'app Stockscreener
1.29
7.50%
0.09
Pre-mercato:
1.23
-0.06
-4.65%
Dermata Therapeutics Inc Borsa (DRMA) Ultime notizie
DRMA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Plus Therapeutics Inc (XMP0.DU) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Dermata shares rise after USPTO issues patent notice of allowance - MSN
Dermata receives Australian patent acceptance for topical filler - Investing.com Australia
Dermata Therapeutics Receives Australian Patent Acceptance for Bioneedle Dermal Filler Delivery System - geneonline.com
Dermata receives Australian patent acceptance for topical filler By Investing.com - Investing.com Canada
Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System - The Batesville Daily Guard
Dermata clears Australian patent hurdle for topical dermal fillers - Stock Titan
Maxim Group Maintains Dermata Therapeutics(DRMA.US) With Buy Rating, Cuts Target Price to $4 - Moomoo
Guidance Update: Will Dermata Therapeutics Inc Equity Warrant benefit from AI trendsMarket Sentiment Report & Verified Short-Term Plans - baoquankhu1.vn
Tangible book value per share of Dermata Therapeutics, Inc. – NASDAQ:DRMAW - TradingView
Total debt per share of Dermata Therapeutics, Inc. – NASDAQ:DRMAW - TradingView
Aug Levels: Will Dermata Therapeutics Inc benefit from seasonality2026 Summary & Stepwise Trade Signal Guides - baoquankhu1.vn
Quarterly Trades: Is Dermata Therapeutics Inc stock forming a cup and handleQuarterly Portfolio Review & Weekly Watchlist of Top Performers - baoquankhu1.vn
Dermata Therapeutics Reports Increased Losses in FY Earnings - Intellectia AI
Dermata Therapeutics 2025 Financial Update - AlphaStreet
Dermata Therapeutics Inc stock rises amid market gains - Intellectia AI
Southland Holdings, Inc. (SLND) Reports Wider Q4 Loss Than Expected - news.alphastreet.com
Dermata Therapeutics Announces Strategic Pivot to DTC Skincare with Tome Brand and Plans 2026 Product Launch - Minichart
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025 - Bitget
Dermata Therapeutics 10-K: $7.56M net loss, operating expenses $7.77M - TradingView
Dermata Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
Dermata Therapeutics (NASDAQ: DRMA) pivots from Rx acne to Tome OTC skincare - Stock Titan
Dermata (NASDAQ: DRMA) shifts to DTC skincare as 2025 loss shrinks - Stock Titan
Analyst Downgrade: Will Dermata Therapeutics Inc benefit from AI trendsLong Setup & Precise Swing Trade Alerts - baoquankhu1.vn
Dermata Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt - MarketScreener
Risk Recap: Is Dermata Therapeutics Inc Equity Warrant a strong candidate for buy and hold2026 Top Decliners & Comprehensive Market Scan Reports - baoquankhu1.vn
Fennec Pharmaceuticals Inc. (FENC) Misses Q4 EPS Estimates - AlphaStreet
If You Invested $1,000 in Protagenic Therapeutics Inc (PTIX) - Stock Titan
If You Invested $1,000 in THERIVA BIOLOGICS INC (TOVX) - Stock Titan
Valuation Update: Is Dermata Therapeutics Inc. Equity Warrant stock risky to hold now2026 Summary & Safe Entry Point Identification - baoquankhu1.vn
Dermata Therapeutics Poised for Expansion with Strategic Skincare Launch - timothysykes.com
Dermata Therapeutics Strategically Pivots with New Skincare Launch - StocksToTrade
Dermata Therapeutics Strategically Expands into Skincare with Executive Appointment - timothysykes.com
Why Planet Labs Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket - Sahm
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session. - ChartMill
Dermata Therapeutics Ramps Up Skincare Division with New VP Appointment - StocksToTrade
Dermata’s Strategic Pivot: New Skincare Line on the Horizon - timothysykes.com
Stay updated with the stocks that are on the move in today's pre-market session. - ChartMill
Dermata Gears Up For First Once-Weekly Acne Kit Launch, Eyeing A Slice Of $3.8B Market - RTTNews
12 Health Care Stocks Moving In Friday's Pre-Market SessionAzitra (AMEX:AZTR), Bullfrog AI Hldgs (NASDAQ:BFRG) - benzinga.com
Get insights into the top gainers and losers of Thursday's after-hours session. - ChartMill
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Published on: 2026-03-20 05:04:24 - baoquankhu1.vn
Trevi Therapeutics (TRVI) Q4 Loss Narrows to $0.06/Share vs $0.10 Estimate, 37% Better Than Expected - AlphaStreet
Dermata Therapeutics (DRMAW) Expected to Announce Earnings on Wednesday - Defense World
Dermata Therapeutics (DRMA) SVP adds 1,000 shares in insider buy - stocktitan.net
CEO Change: Whats the outlook for Dermata Therapeutics Incs sectorQuarterly Profit Summary & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Dermata Therapeutics Inc. (DRMA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Dermata Therapeutics Inc expected to post a loss of $1.54 a shareEarnings Preview - TradingView
Dermata Therapeutics names Kyra Peckaitis VP of marketing By Investing.com - Investing.com Canada
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):